CIK 0001699382
- Non-accelerated filer
- Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463218129
- Phone
- +1 609-642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-29 | Boxer Capital, LLC Former 10% Owner | Conversion | +28,129 | 60,837 | ||
| 2020-09-29 | Boxer Capital, LLC Former 10% Owner | Conversion · Series C Preferred Stock | −586,099 | 0 | ||
| 2020-09-29 | Boxer Capital, LLC Former 10% Owner | Conversion · Series C Preferred Stock | −32,708 | 0 | ||
| 2020-09-29 | Boxer Capital, LLC Former 10% Owner | Conversion · Series D Preferred Stock | −732,137 | 0 | ||
| 2020-09-29 | Boxer Capital, LLC Former 10% Owner | Conversion · Series D Preferred Stock | −28,129 | 0 | ||
| 2020-09-29 | ORBIMED ADVISORS LLC Director | Conversion | +4,025,076 | 4,500,076 | ||
| 2020-09-29 | ORBIMED ADVISORS LLC Director | Conversion | +1,076,891 | 5,576,967 | ||
| 2020-09-29 | ORBIMED ADVISORS LLC Director | Conversion | +518,191 | 6,095,158 | ||
| 2020-09-29 | ORBIMED ADVISORS LLC Director | Conversion | +380,133 | 6,475,291 | ||
| 2020-09-29 | ORBIMED ADVISORS LLC Director | Conversion | +114,039 | 114,039 | ||
| 2020-09-29 | ORBIMED ADVISORS LLC Director | Conversion · Series A Preferred Stock | −4,025,076 | 0 | ||
| 2020-09-29 | ORBIMED ADVISORS LLC Director | Conversion · Series B Preferred Stock | −1,076,891 | 0 | ||
| 2020-09-29 | ORBIMED ADVISORS LLC Director | Conversion · Series C Preferred Stock | −518,191 | 0 | ||
| 2020-09-29 | ORBIMED ADVISORS LLC Director | Conversion · Series D Preferred Stock | −380,133 | 0 | ||
| 2020-09-29 | ORBIMED ADVISORS LLC Director | Conversion · Series D Preferred Stock | −114,039 | 0 | ||
| 2020-09-29 | Thompson Peter A. Director | Conversion | +4,025,076 | 4,500,076 | ||
| 2020-09-29 | Thompson Peter A. Director | Conversion | +1,076,891 | 5,576,967 | ||
| 2020-09-29 | Thompson Peter A. Director | Conversion | +518,191 | 6,095,158 | ||
| 2020-09-29 | Thompson Peter A. Director | Conversion | +380,133 | 6,475,291 | ||
| 2020-09-29 | Thompson Peter A. Director | Conversion | +114,039 | 114,039 |
Page 21 of 23 · 457 trades